HomeCMPX • NASDAQ
add
Compass Therapeutics Inc.
Previous close
$2.90
Day range
$2.60 - $3.02
Year range
$0.77 - $4.08
Market cap
375.62M USD
Avg Volume
1.32M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 0.00 | — |
Operating expense | 16.57M | 7.67% |
Net income | -15.03M | -12.06% |
Net profit margin | — | — |
Earnings per share | -0.11 | 0.00% |
EBITDA | -16.43M | -7.89% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 126.72M | -16.88% |
Total assets | 140.40M | -10.50% |
Total liabilities | 15.17M | 81.96% |
Total equity | 125.23M | — |
Shares outstanding | 138.28M | — |
Price to book | 3.19 | — |
Return on assets | -28.62% | — |
Return on capital | -29.90% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -15.03M | -12.06% |
Cash from operations | -9.16M | 25.84% |
Cash from investing | 15.37M | 143.43% |
Cash from financing | -94.00K | 40.51% |
Net change in cash | 6.11M | 198.64% |
Free cash flow | -3.39M | 54.44% |
About
Founded
2014
Headquarters
Website
Employees
35
